VIVIMEDLAB
vs
ROG
VIVIMEDLAB
ROG
Over the past 12 months, VIVIMEDLAB has underperformed ROG, delivering a return of 0% compared to the ROG's +24% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
VIVIMEDLAB
ROG
See Who Stands Out.
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Vivimed Labs Ltd
NSE:VIVIMEDLAB
|
4.95
INR
|
|||||
|
Roche Holding AG
SIX:ROG
|
366.1
CHF
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
VIVIMEDLAB, ROG
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Vivimed Labs Ltd
Revenue
|
|||||||||||
|
Roche Holding AG
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
VIVIMEDLAB, ROG
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Vivimed Labs Ltd
NSE:VIVIMEDLAB
|
|||||||||
|
Roche Holding AG
SIX:ROG
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Vivimed Labs Ltd | ||||
|
Roche Holding AG | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Compare company's balance sheet with its competitors.
Stocks Performance
Stocks Performance
VIVIMEDLAB, ROG
Performance Gap
VIVIMEDLAB, ROG
Performance By Year
VIVIMEDLAB, ROG
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| UK |
|
GSK plc
XETRA:GS71
|